ClinVar Miner

Submissions for variant NM_000535.7(PMS2):c.746_753del (p.Asp249fs) (rs587782710)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV000132182 SCV000187261 pathogenic Hereditary cancer-predisposing syndrome 2014-03-20 criteria provided, single submitter clinical testing
Ambry Genetics RCV000222778 SCV000275106 pathogenic Tumor susceptibility linked to germline BAP1 mutations 2015-04-10 criteria provided, single submitter clinical testing
GeneDx RCV000657186 SCV000778908 pathogenic not provided 2017-08-16 criteria provided, single submitter clinical testing This deletion of eight nucleotides in PMS2 is denoted c.746_753delACTCCGTG at the cDNA level and p.Asp249ValfsX2 (D249VfsX2) at the protein level. The normal sequence, with the bases that are deleted in brackets, is AGTG[delACTCCGTG]TGTG. The deletion causes a frameshift, which changes an Aspartic Acid to a Valine at codon 249, and creates a premature stop codon at position 2 of the new reading frame. This variant is predicted to cause loss of normal protein function through either protein truncation or nonsense-mediated mRNA decay. PMS2 c.746_753delACTCCGTG has been reported in individuals with colon cancer (Talseth-Palmer 2010, Goodenberger 2016). We consider this variant to be pathogenic.
Invitae RCV000227297 SCV000285153 pathogenic Hereditary nonpolyposis colon cancer 2018-10-23 criteria provided, single submitter clinical testing This sequence change deletes 8 nucleotides from exon 7 of the PMS2 mRNA (c.746_753delACTCCGTG), causing a frameshift at codon 249. This creates a premature translational stop signal (p.Asp249Valfs*2) and is expected to result in an absent or disrupted protein product. Loss-of-function variants in PMS2 are known to be pathogenic. This particular variant has been reported in the literature in individuals affected with colorectal cancer and suspected Lynch syndrome (PMID: 20487569, 25980754, 27435373, 27064304). For these reasons, this variant has been classified as Pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.